Evidence map›Paper›PMID 38668590›Full record

ArticleToxins2024

Snakebites in Cameroon: Tolerance of a Snake Antivenom (Inoserp™ PAN-AFRICA) in Africa in Real-Life Conditions.

David Benhammou, Jean-Philippe Chippaux, Rodrigue Ntone, Yoann Madec, Pierre Amta, Gaëlle Noel, Fai Njuwa Karl, Anaïs Perilhou, Lucrece Matchim, Marie Sanchez and 6 more

Registry-linked trialOpen access · goldAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Toxins, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03326492 (Evaluation of Anti-venoms Serum in Africa), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03326492 completednot on this map

Evaluation of Anti-venoms Serum in Africa (ESAA). Data Collection in Real Life Conditions

TypeobservationalSponsorInstitut PasteurRan2019 to 2021Enrolled474ConditionsSnake Bites, Antivenins, Snake VenomsArmsAntivenom serum Inoserp Pan-Africa® injection
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Snakebites in Cameroon by Species Whose Effects Are Poorly Described.Tropical medicine and infectious disease · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 4 countries.

David BenhammouEmerging Diseases Epidemiology Unit, Institut Pasteur, Paris Cité University, F-75015 Paris, France.
Jean-Philippe ChippauxMERIT Unit, Institut de Recherche pour le Développement, Paris Cité University, F-75006 Paris, France.ORCID 0000-0002-1976-8568
Rodrigue NtoneEpicentre Yaounde, Yaounde BP 12069, Cameroon.
Yoann MadecEmerging Diseases Epidemiology Unit, Institut Pasteur, Paris Cité University, F-75015 Paris, France.
Pierre AmtaTokombere Hospital, Tokombere, Mora BP 74, Cameroon.
Gaëlle NoelInstitut Pasteur, Translational Research Center, Paris Cité University, F-75015 Paris, France.
Fai Njuwa KarlEpicentre Yaounde, Yaounde BP 12069, Cameroon.ORCID 0000-0001-5395-0091
Anaïs PerilhouInstitut Pasteur, Clinical Research Coordination Center, Paris Cité University, F-75015 Paris, France.
Lucrece MatchimEpicentre Yaounde, Yaounde BP 12069, Cameroon.ORCID 0000-0003-0539-7556
Marie SanchezInstitut Pasteur, Data Management Core Facility, Paris Cité University, F-75015 Paris, France.
Mark NdifonEpicentre Yaounde, Yaounde BP 12069, Cameroon.
Pedro ClauteauxInstitut Pasteur, Translational Research Center, Paris Cité University, F-75015 Paris, France.
Lucrèce EtekiEpicentre Yaounde, Yaounde BP 12069, Cameroon.
Yap BoumEpicentre Yaounde, Yaounde BP 12069, Cameroon.
Armand Seraphin NkwescheuCameroon Society of Epidemiology, Yaounde BP 1411, Cameroon.
Fabien TaiebInstitut Pasteur Medical Center, Paris Cité University, F-75015 Paris, France.ORCID 0000-0002-0941-2859
Institut Pasteur · FRUniversité de Yaoundé I · CMCameroon Nutritional Science Society · CMTokuyama (Japan) · JPUniversité Paris Cité · FR

Funding

Inosan Biopharma 18 07 008-00Institut Pasteur 18 07 008-00
6 · The paper itself

Abstract

Snakebite envenomation (SBE) is a public health issue in sub-Saharan countries. Antivenom is the only etiological treatment. Excellent tolerance is essential in managing SBE successfully. This study aimed to evaluate tolerance of Inoserp

Indexed as

AntiveninsSnake BitesAdolescentAdultAgedAged, 80 and overAnimalsCameroonChildChild, PreschoolDrug ToleranceFemaleHumansMaleMiddle AgedSnake VenomsAntiveninsSnake VenomsantivenomCameroonenvenomationsnakebitesub-Saharan Africatolerancetreatment

Identifiers

PMID38668590
PMCPMC11053651
OpenAlexW4393094263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.